EUVIMEDTutustu EUVIMEDiin
ÜbersichtsarbeitOpen access · CC BY 4.0

Marine-Derived Peptides with Anti-Hypertensive Properties: Prospects for Pharmaceuticals, Supplements, and Functional Food

Mari Johannessen Walquist, Karl-Erik Eilertsen iD, Edel Oddny Elvevoll iD, Ida-Johanne Jensen iD

Marine Drugs · 2024

DOI: 10.3390/md22040140 ↗

At a glance

Übersichtsarbeit in Marine Drugs, 2024. Written by Mari Johannessen Walquist and 3 co-authors. Institution: Faculty of Biosciences, Fisheries and Economics, The Norwegian College of Fishery Science, UiT The Arctic University of Norway, N-9037 Tromsø, Norway. Major MEDLINE topics: Antihypertensive Agents, Aquatic Organisms, Dietary Supplements, Functional Food. Cited 33 times so far (Crossref); 78 references. The full text is freely available (open access, CC BY 4.0). Funded by: UiT The Arctic University of Norway.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Hypertension, a major health concern linked to heart disease and premature mortality, has prompted a search for alternative treatments due to side effects of existing medications. Sustainable harvesting of low-trophic marine organisms not only enhances food security but also provides a variety of bioactive molecules, including peptides. Despite comprising only a fraction of active natural compounds, peptides are ideal for drug development due to their size, stability, and resistance to degradation. Our review evaluates the anti-hypertensive properties of peptides and proteins derived from selected marine invertebrate phyla, examining the various methodologies used and their application in pharmaceuticals, supplements, and functional food. A considerable body of research exists on the anti-hypertensive effects of certain marine invertebrates, yet many species remain unexamined. The array of assessments methods, particularly for ACE inhibition, complicates the comparison of results. The dominance of in vitro and animal in vivo studies indicates a need for more clinical research in order to transition peptides into pharmaceuticals. Our findings lay the groundwork for further exploration of these promising marine invertebrates, emphasizing the need to balance scientific discovery and marine conservation for sustainable resource use.

Subjects

MeSH terms (MEDLINE)

Antihypertensive AgentsAquatic OrganismsDietary SupplementsFunctional FoodInvertebratesPeptidesAnimalsHumansBiological ProductsHypertension

Author keywords

ACE-inhibitionChordataCnidariaEchinodermataMolluscaPoriferaTunicateantihypertensivebioactivityhypertension

Substances

Antihypertensive AgentsBiological ProductsPeptides

Authors and institutions

  • Faculty of Biosciences, Fisheries and Economics, The Norwegian College of Fishery Science, UiT The Arctic University of Norway, N-9037 Tromsø, Norway.
  • Department of Biotechnology and Food Science, Norwegian University of Science and Technology (NTNU), N-7491 Trondheim, Norway.

ORCID profiles: Karl-Erik Eilertsen, Edel Oddny Elvevoll, Ida-Johanne Jensen

Funding

  • UiT The Arctic University of Norway

Cite

APA

Walquist, M. J., Eilertsen, K. E., Elvevoll, E. O., & Jensen, I. J. (2024). Marine-Derived Peptides with Anti-Hypertensive Properties: Prospects for Pharmaceuticals, Supplements, and Functional Food. Marine Drugs. https://doi.org/10.3390/md22040140

Vancouver

Walquist MJ, Eilertsen KE, Elvevoll EO, Jensen IJ. Marine-Derived Peptides with Anti-Hypertensive Properties: Prospects for Pharmaceuticals, Supplements, and Functional Food. Marine Drugs. 2024. doi:10.3390/md22040140

BibTeX
@article{Walquist2024,
  author = {Walquist, Mari Johannessen and Eilertsen, Karl-Erik and Elvevoll, Edel Oddny and Jensen, Ida-Johanne},
  title = {Marine-Derived Peptides with Anti-Hypertensive Properties: Prospects for Pharmaceuticals, Supplements, and Functional Food},
  journal = {Marine Drugs},
  year = {2024},
  doi = {10.3390/md22040140}
}
Start for free →